Literature DB >> 16569712

Randomized controlled trials: do they have external validity for patients with multiple comorbidities?

Martin Fortin1, Jonathan Dionne, Geneviève Pinho, Julie Gignac, José Almirall, Lise Lapointe.   

Abstract

PURPOSE: Many randomized controlled trials (RCTs) exclude patients who have multiple comorbidities. The aim of this study was to illustrate the prevalence of comorbidities among patients followed up in primary care who would have met the inclusion criteria of selected RCTs focusing on treatment of a particular condition. We used hypertension as an example of a particular chronic condition.
METHODS: We used an existing database of 980 patients (660 women) that was representative of a population consulting primary care family doctors and that contained information about all chronic conditions. We randomly selected 5 RCTs that focused on patients with hypertension. The inclusion and exclusion criteria used in each of the 5 RCTs were applied (1 study at a time) to the patients in our database. The patients from our data set who met the inclusion criteria of a given RCT were considered eligible for that RCT.
RESULTS: Of the patients from our data set who were eligible for each of the RCTs, 89% to 100% had multiple chronic conditions. The mean number of chronic conditions of patients eligible for each RCT ranged from 5.5 +/- 3.3 to 11.7 +/- 5.3.
CONCLUSIONS: Results from this study suggest that RCTs targeting a chronic medical condition such as hypertension could find that, in a sample taken from family practice, most eligible patients have comorbid conditions. Whether these patients are sampled or excluded should be reported. Research results intended to be applied in medical practice should take the complex reality of effective treatment of these patients into consideration.

Entities:  

Mesh:

Year:  2006        PMID: 16569712      PMCID: PMC1467012          DOI: 10.1370/afm.516

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  25 in total

1.  Disease management--promises and pitfalls.

Authors:  T Bodenheimer
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245

Review 2.  How to measure comorbidity. a critical review of available methods.

Authors:  Vincent de Groot; Heleen Beckerman; Gustaaf J Lankhorst; Lex M Bouter
Journal:  J Clin Epidemiol       Date:  2003-03       Impact factor: 6.437

Review 3.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care.

Authors:  Linda P Fried; Luigi Ferrucci; Jonathan Darer; Jeff D Williamson; Gerard Anderson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-03       Impact factor: 6.053

4.  Medical practice guidelines: current activities and future directions.

Authors:  A M Audet; S Greenfield; M Field
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

5.  How many problems do family physicians manage at each encounter? A WReN study.

Authors:  John W Beasley; Terry H Hankey; Rodney Erickson; Kurt C Stange; Marlon Mundt; Marguerite Elliott; Pamela Wiesen; James Bobula
Journal:  Ann Fam Med       Date:  2004 Sep-Oct       Impact factor: 5.166

Review 6.  Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications.

Authors:  R B Haynes; K A McKibbon; R Kanani
Journal:  Lancet       Date:  1996-08-10       Impact factor: 79.321

7.  The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Authors:  Nadia A Khan; Finlay A McAlister; Norman R C Campbell; Ross D Feldman; Simon Rabkin; Jeff Mahon; Richard Lewanczuk; Kelly B Zarnke; Brenda Hemmelgarn; Marcel Lebel; Mitchell Levine; Carol Herbert
Journal:  Can J Cardiol       Date:  2004-01       Impact factor: 5.223

8.  The 2004 Canadian recommendations for the management of hypertension: Part III--Lifestyle modifications to prevent and control hypertension.

Authors:  R M Touyz; N Campbell; A Logan; N Gledhill; R Petrella; R Padwal
Journal:  Can J Cardiol       Date:  2004-01       Impact factor: 5.223

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

10.  Refining the measurement of the economic burden of chronic diseases in Canada.

Authors:  John Rapoport; Philip Jacobs; Neil R Bell; Scott Klarenbach
Journal:  Chronic Dis Can       Date:  2004
View more
  95 in total

1.  Quantifying the longitudinal value of healthcare record collections for pharmacoepidemiology.

Authors:  Matthew Sperrin; Sarah Thew; James Weatherall; William Dixon; Iain Buchan
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

Review 2.  State-of-the-art and future directions in multilevel interventions across the cancer control continuum.

Authors:  Kurt C Stange; Erica S Breslau; Allen J Dietrich; Russell E Glasgow
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

3.  Multiple chronic conditions: a public health challenge.

Authors:  Regina M Benjamin
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

4.  Tramadol for osteoarthritis.

Authors:  Karine Toupin April; Jacinthe Bisaillon; Vivian Welch; Lara J Maxwell; Peter Jüni; Anne Ws Rutjes; M Elaine Husni; Jennifer Vincent; Tania El Hindi; George A Wells; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2019-05-27

5.  Threads and yarns: weaving the tapestry of comorbidity.

Authors:  Barbara Starfield
Journal:  Ann Fam Med       Date:  2006 Mar-Apr       Impact factor: 5.166

6.  On TRACK: medical research must consider context and complexity.

Authors:  Kurt C Stange
Journal:  Ann Fam Med       Date:  2006 Jul-Aug       Impact factor: 5.166

7.  Multimorbidity's many challenges.

Authors:  Martin Fortin; Hassan Soubhi; Catherine Hudon; Elizabeth A Bayliss; Marjan van den Akker
Journal:  BMJ       Date:  2007-05-19

8.  Neglected external validity in reports of randomized trials: the example of hip and knee osteoarthritis.

Authors:  Nizar Ahmad; Isabelle Boutron; David Moher; Isabelle Pitrou; Carine Roy; Philippe Ravaud
Journal:  Arthritis Rheum       Date:  2009-03-15

9.  The problem of fragmentation and the need for integrative solutions.

Authors:  Kurt C Stange
Journal:  Ann Fam Med       Date:  2009 Mar-Apr       Impact factor: 5.166

10.  Does hospital performance on process measures directly measure high quality care or is it a marker of unmeasured care?

Authors:  Rachel M Werner; Eric T Bradlow; David A Asch
Journal:  Health Serv Res       Date:  2007-12-20       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.